XML 84 R77.htm IDEA: XBRL DOCUMENT
v3.24.3

License and Distribution Agreements - Additional Information (Details) - USD ($) $ in Thousands |  |  |  | 3 Months Ended | 9 Months Ended
--- | --- | --- | --- | --- | ---
Dec. 11, 2023 | Aug. 25, 2023 | Mar. 17, 2023 | Mar. 31, 2023 | Sep. 30, 2024
License And Distribution Agreements [Line Items] |  |  |  |  |
License fee payment | $ 300 |  |  |  |
Issuance of common stock |  |  |  | $ 136 |
Common Stock |  |  |  |  |
License And Distribution Agreements [Line Items] |  |  |  |  |
Purchase and sale of shares |  |  |  | 13,296 |
Regeneron Research Collaboration Services Agreement |  |  |  |  |
License And Distribution Agreements [Line Items] |  |  |  |  |
Service agreement term |  | 5 years |  |  |
Notice period |  | 30 days |  |  |
Deferred revenue |  |  |  |  | $ 750
License Agreement with BioCellgraft, Inc. |  |  |  |  |
License And Distribution Agreements [Line Items] |  |  |  |  |
Commercial license to dental products agreement initial period | 4 years |  |  |  |
Commercial license to dental products agreement renewal term | 2 years |  |  |  |
License fees payment period | 2 years |  |  |  |
License fee expense | $ 5,000 |  |  |  |
License fee payment | $ 300 |  |  |  |
Pulthera, LLC Binding Term Sheet |  |  |  |  |
License And Distribution Agreements [Line Items] |  |  |  |  |
Payment of option fee in cash |  |  |  |  | 3,000
Pulthera, LLC Binding Term Sheet | Common Stock |  |  |  |  |
License And Distribution Agreements [Line Items] |  |  |  |  |
Purchase and sale of shares |  |  | 169,492 |  |
Issuance of common stock |  |  |  |  | 1,000
Pulthera, LLC Binding Term Sheet | Research and Development Expense |  |  |  |  |
License And Distribution Agreements [Line Items] |  |  |  |  |
Option fee included in research and development expense |  |  |  |  | $ 3,000

X
- Definition Commercial license to dental products agreement period. + References No definition available. + Details
Name: | celu_CommercialLicenseToDentalProductsAgreementPeriod
Namespace Prefix: | celu_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Commercial license to dental products agreement renewal term. + References No definition available. + Details
Name: | celu_CommercialLicenseToDentalProductsAgreementRenewalTerm
Namespace Prefix: | celu_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition License agreement notice period. + References No definition available. + Details
Name: | celu_LicenseAgreementNoticePeriod
Namespace Prefix: | celu_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition License and distribution agreements. + References No definition available. + Details
Name: | celu_LicenseAndDistributionAgreementsLineItems
Namespace Prefix: | celu_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition License fee expense. + References No definition available. + Details
Name: | celu_LicenseFeeExpense
Namespace Prefix: | celu_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition License fee payment. + References No definition available. + Details
Name: | celu_LicenseFeePayment
Namespace Prefix: | celu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition License fees payment period. + References No definition available. + Details
Name: | celu_LicenseFeesPaymentPeriod
Namespace Prefix: | celu_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Option Fee Expense + References No definition available. + Details
Name: | celu_OptionFeeExpense
Namespace Prefix: | celu_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Payment of option fee in cash. + References No definition available. + Details
Name: | celu_PaymentOfOptionFeeInCash
Namespace Prefix: | celu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Service agreement term. + References No definition available. + Details
Name: | celu_ServiceAgreementTerm
Namespace Prefix: | celu_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(26)(c)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_DeferredRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 205 -Name Accounting Standards Codification -Section 45 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=celu_RegeneronResearchCollaborationServicesAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=celu_LicenseAgreementWithBiocellgraftIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=celu_PultheraLlcBindingTermSheetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |